Astrotech Co. (NASDAQ:ASTC – Get Free Report) saw a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 3,100 shares, a decline of 35.4% from the November 15th total of 4,800 shares. Approximately 0.2% of the company’s stock are sold short. Based on an average trading volume of 19,000 shares, the days-to-cover ratio is currently 0.2 days.
Astrotech Stock Performance
Shares of NASDAQ:ASTC traded up $0.06 during trading hours on Friday, reaching $6.85. The stock had a trading volume of 5,120 shares, compared to its average volume of 13,711. The stock has a market capitalization of $11.65 million, a price-to-earnings ratio of -0.93 and a beta of -0.20. The firm’s 50 day moving average is $7.44 and its 200-day moving average is $8.44. Astrotech has a 1 year low of $6.56 and a 1 year high of $12.29.
Astrotech (NASDAQ:ASTC – Get Free Report) last announced its quarterly earnings results on Thursday, September 19th. The aerospace company reported ($1.78) earnings per share (EPS) for the quarter. The business had revenue of $0.07 million for the quarter. Astrotech had a negative return on equity of 33.26% and a negative net margin of 945.17%.
Astrotech Company Profile
Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, cargo and other secured facilities, and borders.
Recommended Stories
- Five stocks we like better than Astrotech
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Buy P&G Now, Before It Sets A New All-Time High
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Stock Sentiment Analysis: How it Works
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.